Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/XLIFE-SCIENCES-AG-133157244/news/VERAXA-Biotech-AG-u-bernimmt-Synimmune-GmbH-zur-Erweiterung-des-Krebsportfolios-45650798/?utm_source=whatsapp&utm_medium=social&utm_campaign=share